Pardoprunox is a benzoxazolone derivative that acts as a partial dopamine D2 and D3 receptor agonist with serotonergic activity, previously investigated for the treatment of Parkinson’s disease and other… Read more
Pardoprunox is a benzoxazolone derivative that acts as a partial dopamine D2 and D3 receptor agonist with serotonergic activity, previously investigated for the treatment of Parkinson’s disease and other related central nervous system disorders. The Pardoprunox category encompasses the active pharmaceutical ingredient, its metabolites, and specific related impurities necessary for comprehensive analytical testing. Laboratories utilize these high-quality reference standards for impurity profiling, method validation, and stability testing during pharmaceutical development. By providing access to substances like N-desmethyl Pardoprunox and various degradation products, these compounds enable researchers to accurately identify and quantify unknown peaks in chromatographic analysis. Whether establishing potency, conducting routine quality control, or performing stable isotope labelled studies, these reference materials ensure consistent and reliable results in the rigorous assessment of drug purity and regulatory compliance throughout the lifecycle of the compound.